Real-Time Kinase Activity Assays Reveal Cellular Context and Pathway-Specific Activity

AssayQuant's kinase activity assays provide real-time, quantitative data on kinase activity across various cell models. Our assays are designed to deliver accurate and reproducible results, empowering your research and accelerating your drug discovery process.

Selective detection of kinase activity of high-profile oncology-centric targets in crude lysates from multiple cell models using an expanding panel of selective sensor peptides.

Our PhosphoSens™ Lysate Assays don’t just measure enzyme activity—they show how compounds behave in real cellular environments. The data below highlight pathway-specific kinase responses across multiple cell models, revealing insights you won’t see with traditional endpoint assays.

ERK1_2 Activity in Crude Lysates_1-5 μg_well_from 7 Cell Models using AQT1076

ERK1/2 activity using AQT1076 selective sensor peptide (15 µM) with crude lysates (1-5 µg/well) from 7 cell models with or without cell stimulation and the inclusion of the selective ERK1/2 inhibitor SCH772984.

Reaction rates (RFU Corrected/pg of total lysate protein/min) were determined from the slopes using the linear portion of each progress curve. Values are the average of duplicate reactions +/- standard deviation. Green-shaded bars indicate stimulation of the cells before making lysates. Inhibitors confirming the selectivity of the assay were added to the lysate reaction.

AKT1_2_3 Activity in Crude Lysates_2 μg_well_from 13 Cell Models using AQT0982

AKT1/2/3 activity using AQT0982 selective sensor peptide (15 µM) with crude lysates (2 µg/well) from 13 cell lines with or without cell stimulation. Note that the signal with crude lysate from PDGF-treated NIH3T3 cells was completely inhibited with the inclusion of the selective AKT inhibitors Rizavasertib (A-443654) and Vevorisertib (ARQ 751) (1 µM of each; data not shown). 

Reaction rates (RFU Corrected/pg of total lysate protein/min) were determined from the slopes using the linear portion of each progress curve. Values are the average of duplicate reactions +/- standard deviation. Green-shaded bars indicate stimulation of the cells before making lysates. Inhibitors confirming the selectivity of the assay were added to the lysate reaction.

GSK3α_β Activity in Crude Lysates_1.8 μg_well_from 9 Cell Models using AQT1211

GSK3α/β Activity using AQT1211 selective sensor peptide (15 µM) with crude lysates (1.8 µg/well) from 9 cell models with or without stimulation and the inclusion of the selective GSK3α/β inhibitor LY2090314 (1 µM). Growth factor stimulation activates both ERK1/2 (via the RAF/MEK1/2/ERK1/2 pathway) and AKT (via the PI3K pathway), with varying levels of activation in different cell lines and response to various stimuli. With GSK3, its activation is the opposite of AKT, since AKT phosphorylation of GSK3α at Ser21 and GSK3β at Ser9 inhibits GSK3 activity. 

Reaction rates (RFU Corrected/pg of total lysate protein/min) were determined from the slopes using the linear portion of each progress curve. Values are the average of duplicate reactions +/- standard deviation. Green-shaded bars indicate stimulation of the cells before making lysates. Inhibitors confirming the selectivity of the assay were added to the lysate reaction.

INTRODUCTORY OFFER

Discuss your research needs with our kinase assay specialists and explore how real-time data can accelerate your projects.

Book a free, no-obligation meeting with our team to discuss your cell models, pathways of interest, and research goals. We’ll help you determine if our real-time kinase activity assays can accelerate your discoveries.

 

Interested In Learning More?

Download our Cell Lysate Assay Brochure today!